E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Studies on the mechanism of action of metaraminol (aramine).
TL;DR: The clinical effectiveness of metaraminol (Aramine), a widely used sympathomimetic agent, has been well documented, but the mechanism of its action on the heart and circulatory system is still unclear.
Journal ArticleDOI
Percutaneous puncture of the left ventricle
TL;DR: The present report constitutes a description of the techniques and a summary of the experience with the procedure with a minimum of risk and discomfort in this clinic.
Journal ArticleDOI
Effects of Chronic Heart Failure on the Inotropic Response of the Right Ventricle of the Conscious Dog to a Cardiac Glycoside and to Tachycardia
TL;DR: Cardiac glycosides and the Bowditch phenomenon exert relatively minor positive inotropic responses in the nonfailing heart of the conscious dog when compared with the responses to these stimuli in the failing heart.
Journal ArticleDOI
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial.
Benjamin M. Scirica,Christopher P. Cannon,Richard A. Cooper,Richard H. Aster,Jacqueline A. Brassard,Carolyn H. McCabe,Andrew Charlesworth,Allan M. Skene,Eugene Braunwald +8 more
TL;DR: Thrombocytopenia, though uncommon, was associated with orbofiban use and an increased risk of bleeding, but also death and MI, providing further evidence that drugs that lead to thrombocytes are, in a significant proportion of patients associated with thromBotic events.
Journal ArticleDOI
Cardiovascular science: opportunities for translating research into improved care
TL;DR: Cumulatively, it seems likely that the clinical advances emerging from ongoing research will, in the foreseeable future, reduce the number of deaths in the industrialized world from cardiovascular disease.